Close

Merck (MRK), Sun Pharma Enter Global Licensing Agreement for MK-3222

September 17, 2014 8:37 AM EDT Send to a Friend
Merck & Co., Inc., (NYSE: MRK) and Sun Pharmaceutical Industries Ltd. through their respective subsidiaries, announced an exclusive worldwide licensing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login